Theralizumab (TGN1412) is a superagonist anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can be used for the research of rheumatoid arthritis.
Purity:
99.0%
CAS Number:
[906068-56-2]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted